Cap. 578 · Production Of Cannabis For Medicinal (Cap. 578)
Cap. 578 Art. 5782 [CAP. Cap. 31 Cap. 101. Cap. 537. Cap. 325. Cap. 463. Cap. 465. Cap. 465. Cap. 465. Cap. 458. Cap. 465.
MEDICINAL AND RESEARCH PURPOSES
"drugs laws" means the Medical and Kindred Professions
Ordinance, the Dangerous Drugs Ordinance and the Drug Dependence
(Treatment not Imprisonment) Act;
"letter of intent" means a letter issued by Malta Enterprise which shall constitute a preliminary approval and may include inter alia the regulating of assistance under the Malta Enterprise laws, and a letter of intent that includes assistance under the Malta Enterprise laws shall be subject to the provisions of the Malta Enterprise laws, which shall, mutatis mutandis, apply;
"licence" means the approval given by the regulatory authority or any other authority as may from time to time be prescribed;
"Malta Enterprise laws" means the Business Promotion Act and the
Malta Enterprise Act;
"Minister" means the Minister responsible for the Medicines Authority save for the purposes of article 3 and article 5(2) where it shall mean the Minister responsible for industry;
"premises" means the industrial premises where the production of products derived from cannabis, for medicinal and, or research purposes, is to be carried out;
"prescribed" means prescribed by regulations made under the powers conferred by this Act;
"prescribed form" means a form as from time to time published by Malta Enterprise;
"public health" has the same meaning as is assigned to it by article
2 of the Public Health Act;
"public health emergency" has the same meaning as is assigned to it by article 2 of the Public Health Act;
"public health risk" has the same meaning as is assigned to it by article 2 of the Public Health Act;
"regulatory authority" means the authority as established by article
4 of the Medicines Act;
"research" means research for pharmaceutical, pharmacological and, or clinical purposes; and
"superintendent" means the Superintendent of Public Health as established by article 3 of the Public Health Act.